MRSA study: Simple steps slash deadly infections in sickest hospital patientsCenters for Disease Control and Prevention (CDC) sent this bulletin at 05/29/2013 05:09 PM EDT
MRSA study: simple steps slash deadly infections in sickest hospital patients
Bloodstream infections cut by more than 40 percent in study of more than 74,000 patients
Using germ-killing soap and ointment on all intensive-care unit (ICU) patients can reduce bloodstream infections by up to 44 percent and significantly reduce the presence of methicillin-resistant Staphylococcus aureus (MRSA) in ICUs.
The study, known as the REDUCE MRSA trial, was published in today’s New England Journal of Medicine and took place in two stages from 2009-2011. A multidisciplinary team from the University of California, Irvine, Harvard Pilgrim Health Care Institute, Hospital Corporation of America (HCA) and the Centers for Disease Control and Prevention (CDC) carried out the study. A total of 74 adult ICUs and 74,256 patients were part of the study, making it the largest study on this topic to date. Researchers evaluated the effectiveness of three MRSA prevention practices: routine care, providing germ-killing soap and ointment only to patients with MRSA, and providing germ-killing soap and ointment to all ICU patients. In addition to being effective at stopping the spread of MRSA in ICUs, the study found that the use of germ-killing soap and ointment on all ICU patients was effective for preventing infections caused by germs other than MRSA.
Read the entire study in NEJM: http://www.nejm.org/doi/full/10.1056/NEJMoa1207290
Read what people are saying about the REDUCE MRSA trial on CDC's Safe Healthcare blog: http://blogs.cdc.gov/safehealthcare.